Ligand Pharmaceuticals Inc (NASDAQ:LGND)

86.96
BATS BZX Real-Time Price
As of 9:53am ET
 +1.56 / +1.83%
Today’s Change
41.99
Today|||52-Week Range
87.17
+63.43%
Year-to-Date

Today’s Trading

Previous close85.40
Today’s open86.77
Day’s range83.39 - 86.80
Volume7,953
Average volume (3 months)394,615
Market cap$1.7B
Dividend yield--
Data as of 9:39am ET, 04/21/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+41.78%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+31.78%
P/E ratio153.1
Price/Sales16.83
Price/Book63.52

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+0.82+1.36%
CMRXChimerix Inc+0.84+2.19%
NLNKNewLink Genetics Cor...+0.94+1.79%
ZIOPZIOPHARM Oncology In...+0.02+0.14%
Data as of 9:52am ET, 04/21/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.27
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers